Taken together, these data indicate that the balance among PP2A, SET, and CIP2A may play a crucial role not only for maintenance of CML progenitors both in chronic and blastic phase but also for the population of leukemic stem cells showing innate resistance to TKI. This evidence concerns the gene CIP2A and chronic myelogenous leukemia, BCR-ABL1 positive.